Abstract
Purpose
The purpose of the current prospective study was to evaluate the effects of low sodium dialysate on oxidative stress parameters, blood pressure (BP) and endothelial dysfunction in maintenance hemodialysis (HD) patients.
Methods
After baseline measurements were taken, the dialysate sodium concentration was reduced from 140 to 137 mEq/L. Oxidative stress parameters and flow-mediated dilatation (FMD %) were measured before and after 6 months of HD with low sodium dialysate. Interdialytic weight gain (IDWG) and pre- and post-dialysis BP were monitored during the study.
Results
A total of 52 patients were enrolled and 41 patients completed the study. There was a significant reduction in systolic blood pressure at the end of the study [130.00 (90.00–190.00) vs. 120.00 (90.00–150.00), p < 0.001]. Similarly, there were significant improvements in IDWG [2670.00 (1670.00–4300.00) vs. 1986.00 (1099.00–3998.00), p < 0.001] and FMD % [7.26 (4.55–8.56) vs. 9.56 (6.55–12.05), p < 0.001]. Serum MDA levels (p < 0.001) were significantly decreased; serum SOD (p < 0.001) and GPx (p < 0.001) activities were significantly increased after low sodium HD compared to standard sodium HD.
Conclusion
Our data seem to suggest a potential role of 137 mEq/L sodium dialysate for improving hemodynamic status, endothelial function and reducing oxidative stress than 140 mEq/L sodium dialysate in maintenance HD patients.
Similar content being viewed by others
References
Ma KW, Greene EL, Raij L (1992) Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 19(6):505–513
Dursun B, Dursun E, Suleymanlar G et al (2008) Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis. Nephrol Dial Transplant 23(5):1697–1703
Menon V, Gul A, Sarnak MJ (2005) Cardiovascular risk factors in chronic kidney disease. Kidney Int 68(4):1413–1418
Zoccali C, Mallamaci F, Tripepi G (2003) Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 85:105–110
Vaziri ND (2004) Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 24(5):469–473
Ward RA, McLeish KR (2003) Oxidant stress in hemodialysis patients: What are the determining factors? Artif Organs 27(3):230–236
Bossola M, Tazza L (2015) Wishful thinking: the suprisingly sparse evidence for a relationship between oxidative stress and cardiovascular disease in hemodialysis patients. Semin Dial 28(3):224–230
Morris ST, McMurray JJ, Rodger RS, Jardine AG (2000) Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant 15(8):1194–1200
Morris ST, McMurray JJ, Spiers A, Jardine AG (2001) Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 60(3):1077–1082
Kari JA, Donald AE, Vallance DT et al (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52(2):468–472
Dishy V, Sofowora GG, Imamura H et al (2003) Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. J Hypertens 21(1):153–157
Matrougui K, Schiavi P, Guez D, Henrion D (1998) High sodium intake decreases pressure-induced (myogenic) tone and flow-induced dilation in resistance arteries from hypertensive rats. Hypertension 32(1):176–179
Van Stone JC, Bauer J, Carey J (1982) The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients. Am J Kidney Dis 2(1):58–64
Gumrukcuoglu HA, Ari E, Akyol A et al (2012) Effects of lowering dialysate sodium on carotid artery atherosclerosis and endothelial dysfunction in maintenance hemodialysis patients. Int Urol Nephrol 44(6):1833–1839
Kaya Y, Ari E, Demir H et al (2012) Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage. Nephrol Dial Transplant 27(3):1164–1169
Kutlugün AA, Erdem Y, Okutucu S et al (2011) Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease. Nephrol Dial Transplant 26(11):3678–3682
Khoschsorur GA, Winklhofer-Roob BM, Rabl H et al (2000) Evaluation of a sensitive HPLC method for determination of malondialdehyde and application of the method to different biological materials. Chromotographia 52:181–184
Paglia DE, Valentine WN (1967) Studies on quantitative and qualitive characterization of erythrocyte glutathine peroxidase. J Lab Clin Med 70:158–169
Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257–265
Celermajer DS, Sorensen KE, Gooch VM et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115
Kocak H, Gumuslu S, Sahin E et al (2009) Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology (Carlton) 14(3):273–280
Lykkesfeldt J (2007) Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380(1–2):50–58
Oberg BP, McMenamin E, Lucas FL et al (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65(3):1009–1016
Puchades MJ, Saez G, Munos MC et al (2013) Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clin Nephrol 80(3):177–186
Santangelo F, Witko-Sarsat V, Drüeke T, Descamps-Latscha B (2004) Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrol Dial Transplant 19(8):1951–1955
Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J et al (2009) Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Iran J Kidney Dis 3(1):22–27
Stępniewska J, Dołęgowska B, Popińska M et al (2014) Prooxidative-antioxidative balance of cells in different types of renal replacement therapy. Blood Purif 37(1):4–11
Dickinson KM, Keogh JB, Clifton PM (2009) Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 89(2):485–490
Tzemos N, Lim PO, Wong S et al (2008) Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension 51(6):1525–1530
Fang Y, Mu JJ, He LC et al (2006) Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians. Hypertension 48(4):724–729
Dunlop JL, Vandal AC, de Zoysa JR et al (2013) Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol 14:149
Sayarlıoglu H, Erkoc R, Tuncer M et al (2007) Effects of low sodium dialysate in chronic hemodialysis patients: an echocardiographic study. Ren Fail 29(2):143–146
Kalantar-Zadeh K, Regidor DL, Kovesdy CP et al (2009) Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119:671–679
Capusa C, Mircescu G (2010) Oxidative stress, renal anemia, and its therapies: Is there a link? J Ren Nutr 20(5 Suppl):71–76
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Macunluoglu, B., Gumrukcuoglu, H.A., Atakan, A. et al. Lowering dialysate sodium improves systemic oxidative stress in maintenance hemodialysis patients. Int Urol Nephrol 48, 1699–1704 (2016). https://doi.org/10.1007/s11255-016-1367-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-016-1367-z